Keywords

• Vildagliptin Impurity ZA5
• (1r,3R,5R,7S,Z)-N-(2-((S)-2-cyanopyrrolidin-1-yl)-2-oxoethylidene)-3-hydroxyadamantan-1-amine oxide
• C17H23N3O3

Quick Details

• ProName: Vildagliptin Impurity ZA5
• Molecular Formula: C17H23N3O3
• Appearance: White to off white powder
• Application: experiment research
• DeliveryTime: prompt delivery
• PackAge: Food bags, aluminum foil bags
• Port: Shenzhen/hongkong
• ProductionCapacity: 5000 Gram/Year
• Purity: 99%+ HPLC
• Storage: cool and dry
• Transportation: DHL,EMS,TNT,UPS,EMS,by air,by sea;
• LimitNum: 10 Milligram
• Moisture Content: 0.1%
• Impurity: 0.1%

Superiority

• Advantages: As a reference standard for Vildagliptin Impurity ZA5, it has an accurate and clear chemical structure, and has undergone strict purity testing and quality control, with good stability under different storage conditions. It can provide a reliable reference for the quality inspection of vildagliptin bulk drugs and formulations, ensuring the accuracy and repeatability of impurity detection results. It helps pharmaceutical companies and research institutions to effectively carry out quality control in the process of drug research and development and production, meeting the high standards of drug regulation.

•  
• 

Details

Vildagliptin Impurity ZA5

Product Information

•  

  • Product Information

    • Product Number: V005016

    • English Name: Vildagliptin Impurity ZA5

    • English Alias: (1r,3R,5R,7S,Z)-N-(2-((S)-2-cyanopyrrolidin-1-yl)-2-oxoethylidene)-3-hydroxyadamantan-1-amine oxide

    • CAS Number: None

    • Molecular Formula: C17H23N3O3

    • Molecular Weight: 317.38

  • Advantages: As a reference standard for Vildagliptin Impurity ZA5, it has an accurate and clear chemical structure, and has undergone strict purity testing and quality control, with good stability under different storage conditions. It can provide a reliable reference for the quality inspection of vildagliptin bulk drugs and formulations, ensuring the accuracy and repeatability of impurity detection results. It helps pharmaceutical companies and research institutions to effectively carry out quality control in the process of drug research and development and production, meeting the high standards of drug regulation.

  • Applications: It is mainly used in the quality research, impurity analysis, and quality control of vildagliptin bulk drugs and formulations. It is used to establish and validate impurity detection methods such as high-performance liquid chromatography (HPLC) and liquid chromatography - mass spectrometry (LC - MS). In the research and development process of vildagliptin, it is used to study the source and formation mechanism of this impurity, and optimize the synthesis process to reduce impurity generation. In the production process, it is used to monitor the content of Impurity ZA5 in products in real time to ensure that drug quality meets relevant standards and regulatory requirements. It can also be used to evaluate the changes of impurities in vildagliptin drugs during storage and transportation, providing data support for drug stability research.

  • Background Description: Vildagliptin is a drug used for the treatment of type 2 diabetes. In the process of its research and development and production, the presence of impurities may affect the safety, effectiveness, and stability of the drug. To ensure the safety of patients' medication and meet the requirements of drug regulation, strict research and precise control of impurities in vildagliptin are essential. As one of the impurities of vildagliptin, in-depth research on Vildagliptin Impurity ZA5 helps to improve the quality standard system of vildagliptin, enhance drug quality, and ensure the safety and effectiveness of clinical medication.

  • Research Status: Currently, the research on Vildagliptin Impurity ZA5 mainly focuses on the optimization and improvement of impurity analysis methods. By using more advanced detection technologies and instruments, the sensitivity and accuracy of detecting this impurity are improved to achieve precise determination of trace impurities. At the same time, researchers are actively exploring the source and change rules of this impurity during the synthesis and storage of vildagliptin, and reducing the generation and accumulation of impurities by improving process conditions and optimizing the storage environment. In addition, the research on the potential impact of this impurity on the performance and safety of vildagliptin drugs is also gradually underway, aiming to provide a more comprehensive scientific basis for the overall evaluation of vildagliptin quality.